Non-small cell lung cancer
Conditions
Interventions
experiment group:Yifeiqinghuagao
control group:Yifeiqinghuagao simulant
Sponsors
Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1)Patients with post-operative stage II-IIIA NSCLC confirmed by pathology or cytology; 2)No tumor patients were enrolled within one month after the completion of postoperative adjuvant therapy; 3)Preoperative neoadjuvant chemotherapy or postoperative adjuvant chemotherapy regimen should be at least 4 cycles according to the NCCN guidelines (chemotherapy regimen should be platinum containing dual drug regimen); 4)Age =18 years old and =80 years old, both male and female 5) ECOG score 0-2 points; 6) Expected survival =6 months; 7) The patient fully understood the study and had signed the informed consent.
Exclusion criteria
Exclusion criteria: 1) The investigator believes that it is not suitable to participate in the clinical trial; 2)Ex19del/L858R (+) patients taking EGFR-TKI; 3) have a birth plan within one year and have been pregnant or breastfeeding patients; 4) Can not cooperate with the interviewees and allergic to the study drug; 5) In other clinical trials; 6) Any situation that may prevent the subject from completing the follow-up process.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival period; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;two-year disease-free survival rate after surgery;Disease-free survival rate at 1 year after surgery;Symptom evaluation;Quality of Life; | — |
Countries
China
Contacts
Public ContactHou Wei
Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Outcome results
None listed